Clinical trials: Ph1 Positive CML
Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable MR4.5 allowing cessation of…
- Trial name
- TIPI (NCT04070443)
- Testing
- Ponatinib, Imatinib
- Where
- 28 sites in France
- Volunteers
- 170 people
- Sponsor
- Centre Leon Berard